Loading...

We've got a brand new version of Simply Wall St! Try it out

Wattle Health Australia

ASX:WHA
Snowflake Description

Adequate balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
WHA
ASX
A$103M
Market Cap
  1. Home
  2. AU
  3. Food, Beverage & Tobacco
Company description

Wattle Health Australia Limited develops, sources, and markets nutritional dairy, health, and wellness products in Australia. The last earnings update was 23 days ago. More info.


Add to Portfolio Compare Print
  • Wattle Health Australia has significant price volatility in the past 3 months.
WHA Share Price and Events
7 Day Returns
0%
ASX:WHA
-0.4%
AU Food
1.3%
AU Market
1 Year Returns
-49.8%
ASX:WHA
-10%
AU Food
9.9%
AU Market
WHA Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Wattle Health Australia (WHA) 0% 43.2% 3.9% -49.8% - -
AU Food -0.4% 2.4% -2.3% -10% -6.5% 31.9%
AU Market 1.3% -0.6% -1% 9.9% 17.6% 17.8%
1 Year Return vs Industry and Market
  • WHA underperformed the Food industry which returned -10% over the past year.
  • WHA underperformed the Market in Australia which returned 9.9% over the past year.
Price Volatility
WHA
Industry
5yr Volatility vs Market

Value

 Is Wattle Health Australia undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Wattle Health Australia. This is due to cash flow or dividend data being unavailable. The share price is A$0.53.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Wattle Health Australia's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Wattle Health Australia's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
ASX:WHA PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in AUD A$-0.05
ASX:WHA Share Price ** ASX (2019-09-27) in AUD A$0.53
Australia Food Industry PE Ratio Median Figure of 21 Publicly-Listed Food Companies 25.25x
Australia Market PE Ratio Median Figure of 557 Publicly-Listed Companies 17.93x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Wattle Health Australia.

ASX:WHA PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:WHA Share Price ÷ EPS (both in AUD)

= 0.53 ÷ -0.05

-10.4x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Wattle Health Australia is loss making, we can't compare its value to the AU Food industry average.
  • Wattle Health Australia is loss making, we can't compare the value of its earnings to the Australia market.
Price based on expected Growth
Does Wattle Health Australia's expected growth come at a high price?
Raw Data
ASX:WHA PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -10.4x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Australia Food Industry PEG Ratio Median Figure of 13 Publicly-Listed Food Companies 1.47x
Australia Market PEG Ratio Median Figure of 357 Publicly-Listed Companies 1.69x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Wattle Health Australia, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Wattle Health Australia's assets?
Raw Data
ASX:WHA PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in AUD A$0.27
ASX:WHA Share Price * ASX (2019-09-27) in AUD A$0.53
Australia Food Industry PB Ratio Median Figure of 43 Publicly-Listed Food Companies 1.24x
Australia Market PB Ratio Median Figure of 1,705 Publicly-Listed Companies 1.8x
ASX:WHA PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:WHA Share Price ÷ Book Value per Share (both in AUD)

= 0.53 ÷ 0.27

2x

* Primary Listing of Wattle Health Australia.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Wattle Health Australia is overvalued based on assets compared to the AU Food industry average.
X
Value checks
We assess Wattle Health Australia's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Food industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Food industry average (and greater than 0)? (1 check)
  5. Wattle Health Australia has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Wattle Health Australia expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Wattle Health Australia has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
35.7%
Expected Food industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Wattle Health Australia expected to grow at an attractive rate?
  • Unable to compare Wattle Health Australia's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Wattle Health Australia's earnings growth to the Australia market average as no estimate data is available.
  • Unable to compare Wattle Health Australia's revenue growth to the Australia market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
ASX:WHA Future Growth Rates Data Sources
Data Point Source Value (per year)
Australia Food Industry Earnings Growth Rate Market Cap Weighted Average 35.7%
Australia Food Industry Revenue Growth Rate Market Cap Weighted Average 9.1%
Australia Market Earnings Growth Rate Market Cap Weighted Average 10.2%
Australia Market Revenue Growth Rate Market Cap Weighted Average 3.6%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
ASX:WHA Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in AUD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
ASX:WHA Past Financials Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income *
2019-06-30 1 -13 -10
2019-03-31 1 -14 -11
2018-12-31 1 -15 -11
2018-09-30 1 -11 -15
2018-06-30 2 -6 -20
2018-03-31 1 -5 -17
2017-12-31 1 -5 -15
2017-09-30 1 -4 -9
2017-06-30 1 -4 -4
2017-03-31 1 -3 -4
2016-12-31 1 -2 -3
2016-09-30 0 -1 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Wattle Health Australia is high growth as no earnings estimate data is available.
  • Unable to determine if Wattle Health Australia is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
ASX:WHA Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Wattle Health Australia Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:WHA Past Financials Data
Date (Data in AUD Millions) EPS *
2019-06-30 -0.05
2019-03-31 -0.06
2018-12-31 -0.06
2018-09-30 -0.09
2018-06-30 -0.13
2018-03-31 -0.13
2017-12-31 -0.13
2017-09-30 -0.10
2017-06-30 -0.06
2017-03-31 -0.06
2016-12-31 -0.07
2016-09-30 -0.05

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Wattle Health Australia will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine Wattle Health Australia's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Wattle Health Australia's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Food, Beverage & Tobacco companies here
  3. Wattle Health Australia's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Wattle Health Australia's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Australia market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Australia market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Wattle Health Australia has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Wattle Health Australia performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Wattle Health Australia's growth in the last year to its industry (Food).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Wattle Health Australia does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Wattle Health Australia's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Wattle Health Australia's 1-year growth to the AU Food industry average as it is not currently profitable.
Earnings and Revenue History
Wattle Health Australia's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Wattle Health Australia Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:WHA Past Revenue, Cash Flow and Net Income Data
Date (Data in AUD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 0.89 -9.91 9.24
2019-03-31 1.10 -10.51 10.39
2018-12-31 1.37 -11.10 11.55
2018-09-30 1.47 -15.47 16.00
2018-06-30 1.52 -19.83 20.45
2018-03-31 1.16 -17.29 17.28
2017-12-31 0.80 -14.75 14.12
2017-09-30 0.87 -9.45 8.66
2017-06-30 0.94 -4.15 3.21
2017-03-31 0.88 -3.55 3.00
2016-12-31 0.81 -2.94 2.79
2016-09-30 0.41 -1.74 1.58
2016-06-30 0.01 -0.54 0.37
2015-06-30 0.00 -0.32 0.23
2014-06-30 0.46 -0.16 0.10

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Wattle Health Australia has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Wattle Health Australia has efficiently used its assets last year compared to the AU Food industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Wattle Health Australia improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Wattle Health Australia's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Food industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Wattle Health Australia has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Wattle Health Australia's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Wattle Health Australia's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Wattle Health Australia is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Wattle Health Australia's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Wattle Health Australia's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 16.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Wattle Health Australia Company Filings, last reported 3 months ago.

ASX:WHA Past Debt and Equity Data
Date (Data in AUD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 51.44 2.06 18.32
2019-03-31 51.44 2.06 18.32
2018-12-31 57.36 1.21 42.14
2018-09-30 57.36 1.21 42.14
2018-06-30 61.54 0.98 55.84
2018-03-31 61.54 0.98 55.84
2017-12-31 15.30 0.00 9.60
2017-09-30 15.30 0.00 9.60
2017-06-30 6.98 0.00 5.75
2017-03-31 6.98 0.00 5.75
2016-12-31 -0.71 2.52 0.48
2016-09-30 -0.71 2.52 0.48
2016-06-30 -1.59 4.89 2.40
2015-06-30 -1.06 1.33 0.04
2014-06-30 -0.74 1.04 0.01
  • Wattle Health Australia's level of debt (4%) compared to net worth is satisfactory (less than 40%).
  • Wattle Health Australia had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Wattle Health Australia has less than a year of cash runway based on current free cash flow.
  • Wattle Health Australia has less than a year of cash runway if free cash flow continues to grow at historical rates of 86.5% each year.
X
Financial health checks
We assess Wattle Health Australia's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Wattle Health Australia has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Wattle Health Australia's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Wattle Health Australia dividends.
If you bought A$2,000 of Wattle Health Australia shares you are expected to receive A$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Wattle Health Australia's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Wattle Health Australia's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
ASX:WHA Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Australia Food Industry Average Dividend Yield Market Cap Weighted Average of 13 Stocks 3.1%
Australia Market Average Dividend Yield Market Cap Weighted Average of 407 Stocks 4.2%
Australia Minimum Threshold Dividend Yield 10th Percentile 1.6%
Australia Bottom 25% Dividend Yield 25th Percentile 2.5%
Australia Top 25% Dividend Yield 75th Percentile 5.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Wattle Health Australia has not reported any payouts.
  • Unable to verify if Wattle Health Australia's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Wattle Health Australia's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Wattle Health Australia has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Wattle Health Australia's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.6%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Wattle Health Australia afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Wattle Health Australia has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Wattle Health Australia's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Lazarus Karasavvidis
COMPENSATION A$4,498,730
CEO Bio

Mr. Lazarus Karasavvidis is Co-Founded Wattle Health Australia Limited in 2011 and serves as its Executive Chairman. He is Chief Executive Officer at Wattle Health Australia Limited. Mr. Karasavvidis has business experience in Australia and Asia. Mr. Karasavvidis co-founded a highly successful national training and recruitment organisation within Australasia for a ten plus year tenure in a high level management position. Mr. Karasavvidis has also co-founded a consulting services business in Laos, which has two divisions concentrating on unexploded ordinance (UXO) and Biomass.

CEO Compensation
  • Lazarus's compensation has increased whilst company is loss making.
  • Lazarus's remuneration is higher than average for companies of similar size in Australia.
Management Team

Lazarus Karasavvidis

TITLE
Co-Founder
COMPENSATION
A$4M

Martin Glenister

TITLE
Co-Founder & Head of Sales
COMPENSATION
A$2M

George Karafotias

TITLE
Chief Financial Officer
COMPENSATION
A$1M

Angela Coppola

TITLE
Finance & Administration Executive

Georgia Sotiropoulos

TITLE
Executive Director

Kobe Li

TITLE
Company Secretary & Independent Non-Executive Director
TENURE
0.5 yrs
Board of Directors Tenure

Average tenure of the Wattle Health Australia board of directors in years:

2.2
Average Tenure
  • The average tenure for the Wattle Health Australia board of directors is less than 3 years, this suggests a new board.
Board of Directors

Lazarus Karasavvidis

TITLE
Co-Founder
COMPENSATION
A$4M

Georgia Sotiropoulos

TITLE
Executive Director
TENURE
1.3 yrs

Kobe Li

TITLE
Company Secretary & Independent Non-Executive Director
TENURE
0.8 yrs

Eric Jiang

TITLE
Independent Non-Executive Director
COMPENSATION
A$1M
TENURE
3.1 yrs

Peter Biantes

TITLE
Independent Non-Executive Director
COMPENSATION
A$1M
TENURE
3.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (A$) Value (A$)
07. Mar 19 Sell IFM Investors Pty Ltd Company 27. Aug 18 05. Mar 19 -3,627,381 A$1.01 A$-3,679,063
X
Management checks
We assess Wattle Health Australia's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Wattle Health Australia has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Is Wattle Health Australia (ASX:WHA) Weighed On By Its Debt Load?

We can see that Wattle Health Australia Limited (ASX:WHA) does use debt in its business. … View our latest analysis for Wattle Health Australia How Much Debt Does Wattle Health Australia Carry? … ASX:WHA Historical Debt, August 29th 2019 A Look At Wattle Health Australia's Liabilities Zooming in on the latest balance sheet data, we can see that Wattle Health Australia had liabilities of AU$3.77m due within 12 months and liabilities of AU$860.0k due beyond that.

Simply Wall St -

Do Insiders Own Lots Of Shares In Wattle Health Australia Limited (ASX:WHA)?

Wattle Health Australia is not a large company by global standards. … View our latest analysis for Wattle Health Australia ASX:WHA Ownership Summary, May 31st 2019 What Does The Institutional Ownership Tell Us About Wattle Health Australia? … Insider Ownership Of Wattle Health Australia The definition of company insiders can be subjective, and does vary between jurisdictions.

Simply Wall St -

If You Had Bought Wattle Health Australia (ASX:WHA) Stock A Year Ago, You'd Be Sitting On A 67% Loss, Today

Unfortunately, shareholders of Wattle Health Australia Limited (ASX:WHA) have suffered share price declines over the last year. … With just AU$1,372,000 worth of revenue in twelve months, we don't think the market considers Wattle Health Australia to have proven its business plan. … It seems likely some shareholders believe that Wattle Health Australia will significantly advance the business plan before too long.

Simply Wall St -

What Kind Of Shareholders Own Wattle Health Australia Limited (ASX:WHA)?

Every investor in Wattle Health Australia Limited (ASX:WHA) should be aware of the most powerful shareholder groups. … Wattle Health Australia is not a large company by global standards. … View our latest analysis for Wattle Health Australia

Simply Wall St -

Should You Be Concerned About Wattle Health Australia Limited's (ASX:WHA) Investors?

I am going to take a deep dive into Wattle Health Australia Limited’s (ASX:WHA) most recent ownership structure, not a frequent subject of discussion among individual investors. … Differences in ownership structure of companies can have a profound effect on how management's incentives are aligned with shareholder returns, and whether they adhere to corporate governance best practices. … ASX:WHA Ownership Summary July 18th 18

Simply Wall St -

Breaking Down Wattle Health Australia Limited's (ASX:WHA) Ownership Structure

Today, I will be analyzing Wattle Health Australia Limited’s (ASX:WHA) recent ownership structure, an important but not-so-popular subject among individual investors. … Check out our latest analysis for Wattle Health Australia ASX:WHA Ownership_summary May 19th 18 Institutional Ownership Institutional investors transact in large blocks which can influence the momentum of stock prices, at least in the short-term, especially when there is a low level of public shares available on the market to trade. … Private Company Ownership Another important group of owners for potential investors in WHA are private companies that hold a stake of 22.18% in WHA.

Simply Wall St -

Who Owns Wattle Health Australia Limited (ASX:WHA)?

Check out our latest analysis for Wattle Health Australia ASX:WHA Ownership Summary Oct 24th 17 Institutional Ownership Institutional investors are one of the largest group of market participants and their buy-sell decisions on a company's stock can significantly impact prices, more so, when there are relatively small amounts of shares available on the market to trade. … Insider Ownership I find insiders are another important group of stakeholders, who are directly involved in making key decisions related to the use of capital. … ASX:WHA Insider Trading Oct 24th 17 General Public Ownership A substantial ownership of 33.57% in WHA is held by the general public.

Simply Wall St -

Company Info

Description

Wattle Health Australia Limited develops, sources, and markets nutritional dairy, health, and wellness products in Australia. It offers a range of nutritional infant formula dairy products and nutritional dairy products. The company was founded in 2011 and is headquartered in Abbotsford, Australia.

Details
Name: Wattle Health Australia Limited
WHA
Exchange: ASX
Founded: 2011
A$103,086,664
194,503,140
Website: http://www.wattlehealth.com.au
Address: Wattle Health Australia Limited
17/71 Victoria Crescent,
Abbotsford,
Victoria, 3067,
Australia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX WHA Ordinary Shares Australian Securities Exchange AU AUD 15. Mar 2017
DB 22W Ordinary Shares Deutsche Boerse AG DE EUR 15. Mar 2017
CHIA WHA Ordinary Shares Chi-X Australia AU AUD 15. Mar 2017
Number of employees
Current staff
Staff numbers
0
Wattle Health Australia employees.
Industry
Packaged Foods and Meats
Food, Beverage & Tobacco
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/10/13 10:46
End of day share price update: 2019/09/27 00:00
Last earnings filing: 2019/09/20
Last earnings reported: 2019/06/30
Last annual earnings reported: 2019/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.